Parallax Health Sciences Inc
Change company Symbol lookup
Select an option...
PRLX Parallax Health Sciences Inc
AXS AXIS Capital Holdings Ltd
SPNS Sapiens International Corporation NV
SPCE Virgin Galactic Holdings Inc
BBLG Bone Biologics Corp
RPT RPT Realty
CLM Cornerstone Strategic Value Fund
RCI Rogers Communications Inc
ADRA Adara Acquisition Corp
EVTC Evertec Inc
Go

Health Care : Health Care Technology | Small Cap Growth
Company profile

Parallax Health Sciences, Inc. is a healthcare company that is focused on developing products and services and provides remote communication, diagnosis, treatment, and monitoring of patients on a proprietary platform. The Company’s business segments include Remote Patient Monitoring (RPM), Behavioral Health Services (BHS) and Diagnostics/Corporate. The Remote Patient Monitoring segment has developed a distinctive technology platform Fotodigm platform and Fotodigm. Behavioral Health Services segment offers REBOOT and Intrinsic Code technologies. The Diagnostics/Corporate Segment provides management and administrative services to support the Company and consists of certain aspects of the Company’s executive management, corporate relations, legal, compliance, human resources, and corporate information technology and finance departments.

Closing Price
$0.0001
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
0
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.